Myasthenia Gravis [myasthenia gravis]

topical
418
Terms

anti-MuSK myasthenia gravis
generalizovaná myasthenia gravis
myastenie gravis
myasthenia gravis s protilátkami proti MuSK
okulární myasthenia gravis

 

Anti-MuSK Myasthenia Gravis
Muscle-Specific Receptor Tyrosine Kinase Myasthenia Gravis
Muscle-Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis
MuSK MG
MuSK Myasthenia Gravis
Myasthenia Gravis, Generalized
Myasthenia Gravis, Ocular

Persistent link   https://www.medvik.cz/link/D009157
Definition

A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition.

Annotation
"myasthenia" unqualified in foreign titles is more often MYASTHENIA GRAVIS than MUSCLE WEAKNESS but check text; congenital: consider MYASTHENIC SYNDROMES, CONGENITAL or specifics
DUI
D009157 MeSH Browser
CUI
M0014279

Allowable subheadings

BL
blood 12
CF
cerebrospinal fluid
CI
chemically induced 3
CL
classification 17
CO
complications 58
DI
diagnosis 143
DG
diagnostic imaging 3
DH
diet therapy
DT
drug therapy 85
EC
economics 1
EM
embryology 1
EN
enzymology 2
EP
epidemiology 12
EH
ethnology
ET
etiology 49
GE
genetics 4
HI
history 2
IM
immunology 52
ME
metabolism 5
MI
microbiology
MO
mortality 1
NU
nursing 5
PS
parasitology
PA
pathology 31
PP
physiopathology 32
PC
prevention & control 2
PX
psychology 6
RT
radiotherapy
RH
rehabilitation 4
SU
surgery 37
TH
therapy 129
UR
urine
VE
veterinary
VI
virology

C Diseases
C04 Neoplasms 12 774
C04.588 Neoplasms by Site 77
C04.588.614 Nervous System Neoplasms 81
C04.588.614.550 Paraneoplastic Syndromes, Nervous System 67
C04.588.614.550.112 Anti-N-Methyl-D-Aspartate Receptor Encephalitis 31
C04.588.614.550.450 Limbic Encephalitis 28
C04.588.614.550.500 Myasthenia Gravis 418
C04.588.614.550.500.225 Lambert-Eaton Myasthenic Syndrome 36
C04.588.614.550.550 Myelitis, Transverse 24
C04.588.614.550.600 Opsoclonus-Myoclonus Syndrome 6
C04.588.614.550.650 Paraneoplastic Cerebellar Degeneration 11
C04.588.614.550.700 Paraneoplastic Polyneuropathy 14
C04.730 Paraneoplastic Syndromes 192
C04.730.856 Paraneoplastic Syndromes, Nervous System 67
C04.730.856.112 Anti-N-Methyl-D-Aspartate Receptor Encephalitis 31
C04.730.856.437 Limbic Encephalitis 28
C04.730.856.490 Myasthenia Gravis 418
C04.730.856.490.225 Lambert-Eaton Myasthenic Syndrome 36
C04.730.856.543 Myelitis, Transverse 24
C04.730.856.596 Opsoclonus-Myoclonus Syndrome 6
C04.730.856.650 Paraneoplastic Cerebellar Degeneration 11
C04.730.856.700 Paraneoplastic Polyneuropathy 14
C10 Nervous System Diseases 1 878
C10.114 Autoimmune Diseases of the Nervous System 94
C10.114.375 Demyelinating Autoimmune Diseases, CNS 64
C10.114.656 Myasthenia Gravis 418
C10.114.656.150 Lambert-Eaton Myasthenic Syndrome 36
C10.114.656.300 Myasthenia Gravis, Autoimmune, Experimental 3
C10.114.656.650 Myasthenia Gravis, Neonatal 6
C10.114.703 Nervous System Autoimmune Disease, Experimental 2
C10.114.750 Polyradiculoneuropathy 68
C10.114.812 Stiff-Person Syndrome 14
C10.114.843 Uveomeningoencephalitic Syndrome 11
C10.114.875 Vasculitis, Central Nervous System 24
C10.574 Neurodegenerative Diseases 641
C10.574.781 Paraneoplastic Syndromes, Nervous System 67
C10.574.781.249 Anti-N-Methyl-D-Aspartate Receptor Encephalitis 31
C10.574.781.550 Limbic Encephalitis 28
C10.574.781.588 Myasthenia Gravis 418
C10.574.781.588.225 Lambert-Eaton Myasthenic Syndrome 36
C10.574.781.625 Myelitis, Transverse 24
C10.574.781.662 Opsoclonus-Myoclonus Syndrome 6
C10.574.781.700 Paraneoplastic Cerebellar Degeneration 11
C10.574.781.850 Paraneoplastic Polyneuropathy 14
C10.668 Neuromuscular Diseases 330
C10.668.758 Neuromuscular Junction Diseases 50
C10.668.758.200 Botulism 71
C10.668.758.725 Myasthenia Gravis 418
C10.668.758.725.150 Lambert-Eaton Myasthenic Syndrome 36
C10.668.758.725.300 Myasthenia Gravis, Autoimmune, Experimental 3
C10.668.758.725.650 Myasthenia Gravis, Neonatal 6
C10.668.758.800 Myasthenic Syndromes, Congenital 20
C20 Immune System Diseases 746
C20.111 Autoimmune Diseases 1 934
C20.111.258 Autoimmune Diseases of the Nervous System 94
C20.111.258.124 Anti-N-Methyl-D-Aspartate Receptor Encephalitis 31
C20.111.258.250 Demyelinating Autoimmune Diseases, CNS 64
C20.111.258.500 Myasthenia Gravis 418
C20.111.258.500.150 Lambert-Eaton Myasthenic Syndrome 36
C20.111.258.500.300 Myasthenia Gravis, Autoimmune, Experimental 3
C20.111.258.500.650 Myasthenia Gravis, Neonatal 6
C20.111.258.563 Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
C20.111.258.625 Nervous System Autoimmune Disease, Experimental 2
C20.111.258.750 Polyradiculoneuropathy 68
C20.111.258.850 Stiff-Person Syndrome 14
C20.111.258.925 Uveomeningoencephalitic Syndrome 11
C20.111.258.962 Vasculitis, Central Nervous System 24

Congenital myasthenic syndrome with episodic apnea Disease MeSH Browser

Myasthenia Gravis with Thymus Hyperplasia Disease MeSH Browser

Myasthenia, Limb-Girdle, Autoimmune Disease MeSH Browser

Back Add

Narrower terms